Fukuda, M., Shimada, M., Kitazaki, T., Nagashima, S., Hashiguchi, K., Ebi, N., . . . Sugio, K. (2016). Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Thorac Cancer.
Citação norma ChicagoFukuda, Minoru, et al. "Phase I Study of Irinotecan for Previously Treated Lung Cancer Patients With the UGT1A1 * 28 or * 6 Polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)." Thorac Cancer 2016.
MLA CitationFukuda, Minoru, et al. "Phase I Study of Irinotecan for Previously Treated Lung Cancer Patients With the UGT1A1 * 28 or * 6 Polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)." Thorac Cancer 2016.